Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases
Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998 Feb;155(2):264-71. doi: 10.1176/ajp.155.2.264. Erratum in: Am J Psychiatry 1998 Apr;155(4):578. PMID: 9464208.

Results: The children’s symptom onset was acute and dramatic, typically triggered by GABHS infections at a very early age (mean = 6.3 years, SD = 2.7, for tics; mean = 7.4 years, SD = 2.7, for OCD). The PANDAS clinical course was characterized by a relapsing-remitting symptom pattern with significant psychiatric comorbidity accompanying the exacerbations; emotional lability, separation anxiety, nighttime fears and bedtime rituals, cognitive deficits, oppositional behaviors, and motoric hyperactivity were particularly common. Symptom onset was triggered by GABHS infection for 22 (44%) of the children and by pharyngitis (no throat culture obtained) for 14 others (28%). Among the 50 children; there were 144 separate episodes of symptom exacerbation; 45 (31%) were associated with documented GABHS infection, 60 (42%) with symptoms of pharyngitis or upper respiratory infection (no throat culture obtained), and six (4%) with GABHS exposure.

Conclusions: The working diagnostic criteria appear to accurately characterize a homogeneous patient group in which symptom exacerbations are triggered by GABHS infections. The identification of such a subgroup will allow for testing of models of pathogenesis, as well as the development of novel treatment and prevention strategies.

Clinical and diagnostic manifestations of tickborne mixed infection in combination with COVID-19
Shutikova AL, Leonova GN, Popov AF, Shchelkanov MY. Clinical and diagnostic manifestations of tickborne mixed infection in combination with COVID-19. Klin Lab Diagn. 2021 Nov 29;66(11):689-694. English. doi: 10.51620/0869-2084-2021-66-11-689-694. PMID: 34882355.
  • The study investigated the coexistence of pathogens in a patient, focusing on the relationship between laboratory diagnostics and clinical manifestations during SARS-CoV-2 infection in a case of chronic encephalitis-borreliosis.
  • Blood samples collected over a year revealed Lyme disease diagnosed through IgG antibodies to Borrelia, with joint pain and erythema migrans. Subsequently, the patient contracted SARS-CoV-2 during a Lyme disease exacerbation.
  • Treatment improved the underlying disease but led to TBEV activation, possibly due to immune system focus on SARS-CoV-2. Despite TBEV activation, clinical manifestations were absent, suggesting weak virulence. Etiotropic treatment suppressing borreliosis led to TBEV activation, highlighting the dominance of B. burgdorferi in tick-borne infections.